Wetsvoorstel produceren en traceren van medicijnen aangenomen in V.S.

On 27 November 2013 President Barack Obama signed the Drug Quality and Security Act into law. This law gives U.S. health regulators greater oversight of bulk pharmaceutical compounding and strengthens their ability to track drugs through the distribution pipeline.
The law also creates a national set of standards to track pharmaceuticals through the distribution chain to help thwart the introduction of fake medications into the drug supply. In the United States, dozens of states have some type of regulation designed to track a drug's pedigree, but the rules are inconsistent. This law is designed to apply a uniform standard nationwide (Reuters, 27 november 2013).
Klik hier voor het volledige artikel.
Klik hier voor de Drug Quality and Security Act.
Klik hier voor een artikel van Healthcare Packaging over de Drug Quality and Security Act.

Dit bericht is ook opgenomen in ons maandelijkse overzicht, de NVC Members-only Update. Heeft u vragen, neem dan contact met ons op via e-mail of bel: +31-(0)182-512411.